Anika Therapeutics (ANIK) Receivables - Net (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Receivables - Net of $29.7 million for Q2 2026, up 19.83% year-over-year from $24.8 million in Q2 2025, and up 10.44% quarter-over-quarter from $26.9 million in Q1 2026.
Anika Therapeutics (ANIK) Receivables - Net (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Receivables - Net for 17 consecutive years, with $29.7 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Receivables - Net rose 19.83% year-over-year to $29.7 million; the TTM figure through Jun 2026 stood at $29.7 million (up 19.83% YoY), while the FY2025 annual figure was $24.8 million, up 2.03% from the prior year.
- Receivables - Net climbed to $29.7 million in Q2 2026 per ANIK's latest filing, from $26.9 million in the prior quarter.
- Across five years, Receivables - Net topped out at $38.4 million in Q2 2023 and bottomed at $22.7 million in Q1 2025.
- Historically, Receivables - Net has averaged $29.8 million across 5 years, with a median of $29.7 million in 2026.
- Annual changes were most pronounced in 2025 — Receivables - Net plunged 32.7% — and 2026, when it increased 19.83%.
- Anika Therapeutics' Receivables - Net stood at $36.2 million in 2022, then retreated by 25.41% to $27.0 million in 2023, then dropped by 10.0% to $24.3 million in 2024, then rose by 2.03% to $24.8 million in 2025, then grew by 19.52% to $29.7 million in 2026.
- Business Quant data shows ANIK's Receivables - Net at $29.7 million in Q2 2026, $26.9 million in Q1 2026, and $24.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Anika Therapeutics | 282.86 Mn | 244.45 Mn | 21.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.66 Mn |
| Jun 30, 2026 | 29.66 Mn |
| Mar 31, 2026 | 26.86 Mn |
| Mar 31, 2026 | 26.86 Mn |
| Dec 31, 2025 | 24.82 Mn |
| Dec 31, 2025 | 24.82 Mn |
| Sep 30, 2025 | 23.06 Mn |
| Sep 30, 2025 | 23.06 Mn |
| Jun 30, 2025 | 24.75 Mn |
| Jun 30, 2025 | 24.75 Mn |
| Mar 31, 2025 | 22.70 Mn |
| Mar 31, 2025 | 22.70 Mn |
| Dec 31, 2024 | 24.32 Mn |
| Dec 31, 2024 | 24.32 Mn |
| Sep 30, 2024 | 30.93 Mn |
| Sep 30, 2024 | 30.93 Mn |
| Jun 30, 2024 | 35.40 Mn |
| Jun 30, 2024 | 35.40 Mn |
| Mar 31, 2024 | 33.74 Mn |
| Mar 31, 2024 | 33.74 Mn |